289 related articles for article (PubMed ID: 28237400)
1. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
[TBL] [Abstract][Full Text] [Related]
2. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
4. External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
Prabhu RS; Press RH; Boselli DM; Miller KR; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Burri SH
J Neurooncol; 2018 Mar; 137(1):147-154. PubMed ID: 29218431
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
6. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
Louie AV; Haasbeek CJ; Mokhles S; Rodrigues GB; Stephans KL; Lagerwaard FJ; Palma DA; Videtic GM; Warner A; Takkenberg JJ; Reddy CA; Maat AP; Woody NM; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):82-90. PubMed ID: 26138912
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
8. Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer.
Kakusa B; Han S; Aggarwal S; Liu B; Li G; Soltys S; Hayden Gephart M
J Neurooncol; 2018 Dec; 140(3):705-715. PubMed ID: 30460628
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
10. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms.
Nieder C; Mehta MP; Geinitz H; Grosu AL
Crit Rev Oncol Hematol; 2018 Jun; 126():13-18. PubMed ID: 29759555
[TBL] [Abstract][Full Text] [Related]
12. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M
Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery.
Zindler JD; Rodrigues G; Haasbeek CJ; De Haan PF; Meijer OW; Slotman BJ; Lagerwaard FJ
Radiother Oncol; 2013 Mar; 106(3):370-4. PubMed ID: 23522151
[TBL] [Abstract][Full Text] [Related]
14. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
[TBL] [Abstract][Full Text] [Related]
15. Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.
Tanadini-Lang S; Rieber J; Filippi AR; Fode MM; Streblow J; Adebahr S; Andratschke N; Blanck O; Boda-Heggemann J; Duma M; Eble MJ; Ernst I; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lohaus F; Petersen C; Schrade E; Wendt TG; Wittig A; Høyer M; Ricardi U; Sterzing F; Guckenberger M
Radiother Oncol; 2017 May; 123(2):182-188. PubMed ID: 28169042
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
17. The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma.
Duijm M; Oomen-de Hoop E; van Voort van der Zyp N; van de Vaart P; Tekatli H; Hoogeman M; Senan S; Nuyttens J
Radiother Oncol; 2021 Mar; 156():223-230. PubMed ID: 33418006
[TBL] [Abstract][Full Text] [Related]
18. Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.
Ayala-Peacock DN; Attia A; Braunstein SE; Ahluwalia MS; Hepel J; Chung C; Contessa J; McTyre E; Peiffer AM; Lucas JT; Isom S; Pajewski NM; Kotecha R; Stavas MJ; Page BR; Kleinberg L; Shen C; Taylor RB; Onyeuku NE; Hyde AT; Gorovets D; Chao ST; Corso C; Ruiz J; Watabe K; Tatter SB; Zadeh G; Chiang VLS; Fiveash JB; Chan MD
J Neurooncol; 2017 Nov; 135(2):403-411. PubMed ID: 28828698
[TBL] [Abstract][Full Text] [Related]
19. A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases.
Rodrigues G; Warner A; Zindler J; Slotman B; Lagerwaard F
Radiother Oncol; 2014 Apr; 111(1):52-8. PubMed ID: 24444529
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients.
Egelmeer AG; Velazquez ER; de Jong JM; Oberije C; Geussens Y; Nuyts S; Kremer B; Rietveld D; Leemans CR; de Jong MC; Rasch C; Hoebers F; Homer J; Slevin N; West C; Lambin P
Radiother Oncol; 2011 Jul; 100(1):108-15. PubMed ID: 21784544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
